Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.